Delivery Order SPE2DB22D2007-SPE2DB24FJ3XW

Award Date 7/3/24
Potential Completion Date 7/25/24
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,371.32 firm fixed-price delivery order is for the provision of Kineret 100 mg/0.67 ml syringes. The contract has a period of performance through July 17, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA). The $3,580.88 firm fixed-price delivery order is for the medical product "KINERET 100 MG/0.67 ML SYRINGE 0.67ML". The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, involves the delivery of KINERET 100 MG/0.67 ML SYRINGE 0.67ML to the Defense Logistics Agency (DLA). The $1,790.44 firm fixed-price delivery order has an ultimate completion date of July 23, 2025. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which provides global pharmaceutical...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide KINERET 100 MG/0.67 ML SYRINGE 0.67ML pharmaceuticals. The $1,614.32 contract has a performance period through March 7, 2024 and does not utilize any set-aside designations. This award is part of Amerisourcebergen Drug Corp's broader indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December...
This federal contract award to AmerisourceBergen Drug Corp is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999 through December 2025. The delivery order is for the supply of 4,565,638,353 units of the pharmaceutical product KINERET 100 MG/0.67 ML SYRINGE 0.67ML, with a ceiling value of $8,071.60. This contract does not have a set-aside designation and is a firm-fixed-price arrangement....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $11,300.24 firm fixed price delivery order is for the supply of Kineret 100 mg/0.67 ml syringes. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $4,476.10 and covers the delivery of 4567683987 ! KINERET 100 MG/0.67 ML SYRINGE 0.67ML, a specialty pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 15, 2025. Amerisourcebergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,340.20 Firm Fixed Price delivery order is for the supply of the medication Kineret 100 mg/0.67 ml syringe. The contract has an ultimate completion date of December 11, 2024 and was awarded on November 19, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $5,371.32, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of Kineret 100 mg/0.67 ml syringes, a medication used to treat various medical conditions. The contract is not set aside and is a firm fixed-price arrangement. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,380.62 firm fixed-price delivery order is for the supply of 4,561,232,022 units of the medication Kineret 100 mg/0.67 mL syringe. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB24FJ3XW
    Delivery Order

This federal contract award is for the delivery of KINERET 100 MG/0.67 ML SYRINGE 0.67ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $2,421.48 Firm Fixed Price Delivery Order was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government.

Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical through December 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.

Generated 10/2/24, 9:44 AM